Tuesday, 02 January 2024 12:17 GMT

420 With CNW - The Supreme Court Could Advance Marijuana Reform Amid Trump's Inaction


(MENAFN- Investor Brand Network) The future of federal cannabis policy is once again in uncertainty as the Trump administration sends mixed signals on marijuana reform. On one hand, Trump has voiced support for medical marijuana and hinted that he may consider reclassifying it.

Marijuana firms across the board, including companies like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) , will be following these issues before the Supreme Court to see how the outcomes could impact the trajectory of the industry in the U.S.

Read More>>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: /Disclaimer

CannabisNewsWire
Denver, CO

303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

MENAFN27082025000224011066ID1109981594



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.